{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:42:33Z","timestamp":1788871353964,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100013207","name":"Reckitt Benckiser Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013207","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.drugalcdep.2014.09.775","type":"journal-article","created":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T04:55:30Z","timestamp":1412052930000},"page":"254-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Comparative prices of diverted buprenorphine\/naloxone and buprenorphine in a UK prison setting: A cross-sectional survey of drug using prisoners"],"prefix":"10.1016","volume":"144","author":[{"given":"Nat M.J.","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanib","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth J.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2014.09.775_bib0505","first-page":"533","article-title":"Abuse liability Buprenorphine-naloxone tablets in untreated IV drug abusers","volume":"22","author":"Alho","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugalcdep.2014.09.775_bib0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ADM.0b013e3182034e31","article-title":"Illicit use of buprenorphine\/naloxone among injecting and noninjecting opioid users","volume":"5","author":"Bazazi","year":"2011","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2014.09.775_bib0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1360-0443.2006.01316.x","article-title":"Substance abuse and dependence in prisoners: a systematic review","volume":"101","author":"Fazel","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.09.775_bib0040","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jsat.2012.10.005","article-title":"Forced withdrawal from methadone maintenance therapy in criminal justice settings: a critical treatment barrier in the United States","volume":"44","author":"Fu","year":"2013","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2014.09.775_bib0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/10509670903534951","article-title":"Developing and implementing a new prison-based buprenorphine treatment program","volume":"49","author":"Kinlock","year":"2010","journal-title":"J. Offender Rehabil."},{"key":"10.1016\/j.drugalcdep.2014.09.775_bib0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000313336","article-title":"Naltrexone implants compared to methadone: outcomes six months after prison release","volume":"16","author":"Lobmaier","year":"2010","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2014.09.775_bib0060","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/j.1360-0443.2011.03424.x","article-title":"The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine\/naloxone tablets in opioid users","volume":"106","author":"Middleton","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.09.775_bib0065","series-title":"A Survey of Buprenorphine Misuse in Prison","author":"Ministry of Justice","year":"2007"},{"key":"10.1016\/j.drugalcdep.2014.09.775_bib0070","unstructured":"National Institute for Health and Clinical Excellence, 2007. Drug misuse \u2013 methadone and buprenorphine: full guidance. Available from: \u3008http:\/\/www.nice.org.uk\/nicemedia\/pdf\/TA114Niceguidance.pdf\u3009 (accessed 04.03.14.)."},{"key":"10.1016\/j.drugalcdep.2014.09.775_bib0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.drugalcdep.2009.06.015","article-title":"Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey","volume":"105","author":"Nunn","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.09.775_bib0080","unstructured":"Reckitt Benckiser Pharmaceuticals Inc., 2014. Multiple Dose Study of Blockade of Opioid Effects of Subcutaneous Injections of Buprenorphine in Participants With Opioid Use Disorder. \u3008http:\/\/clinicaltrials.gov\/ct2\/show\/NCT02044094?term=Buprenorphine+naloxone+depot+injection&rank=1\u3009 (accessed 14.02.14.)."},{"key":"10.1016\/j.drugalcdep.2014.09.775_bib0095","unstructured":"Silverman, J., 2006. Prisoners who take on the system. \u3008http:\/\/news.bbc.co.uk\/1\/hi\/uk\/6146606.stm\u3009 (accessed 13.12.13.)."},{"key":"10.1016\/j.drugalcdep.2014.09.775_bib0100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000279766","article-title":"Bioavailability of buprenorphine from crushed and whole buprenorphine (Subutex) tablets","volume":"16","author":"Simojoki","year":"2010","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2014.09.775_bib0105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1300\/J069v26n03_12","article-title":"Abuse of buprenorphine in the United States: 2003\u20132005","volume":"26","author":"Smith","year":"2007","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2014.09.775_bib0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2003.11.008","article-title":"Relative bioavailability of different buprenorphine formulations under chronic conditions","volume":"74","author":"Strain","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.09.775_bib0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/17449200902880482","article-title":"Exploring buprenorphine misuse in prisons: a qualitative study of former prisoners","volume":"5","author":"Tompkins","year":"2009","journal-title":"Int. J. Prison. Health"},{"key":"10.1016\/j.drugalcdep.2014.09.775_bib0120","series-title":"World Prison Population List (tenth edition)","author":"Walmsley","year":"2013"},{"key":"10.1016\/j.drugalcdep.2014.09.775_bib0130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2009.03.008","article-title":"Open-label dose-finding trial of buprenorphine implants (Probuphine) (R) for treatment of heroin dependence","volume":"103","author":"White","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.09.775_bib0145","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.drugpo.2009.03.001","article-title":"A qualitative inquiry into methadone maintenance treatment for opioid-dependent prisoners in Tehran, Iran","volume":"21","author":"Zamani","year":"2010","journal-title":"Int. J. Drug Policy"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614018377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614018377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T04:32:14Z","timestamp":1589257934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871614018377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":19,"alternative-id":["S0376871614018377"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.09.775","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative prices of diverted buprenorphine\/naloxone and buprenorphine in a UK prison setting: A cross-sectional survey of drug using prisoners","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.09.775","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}